Clinical Trial Detail

NCT ID NCT02451553
Title Afatinib Dimaleate and Capecitabine in Treating Patients With Advanced Refractory Solid Tumors, Pancreatic Cancer or Biliary Cancer
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements no
Sponsors University of Washington
Indications

biliary tract cancer

pancreatic cancer

Advanced Solid Tumor

Therapies

Afatinib

Capecitabine

Age Groups: adult

No variant requirements are available.